# Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

> clinical trial · VERIFIED · 2026-07-02

Status: ACTIVE_NOT_RECRUITING · Sponsor: Eli Lilly and Company · Condition: Acute Myeloid Leukemia (AML)

- Company: Eli Lilly and Company
- Sector: pharma
- Primary source: https://clinicaltrials.gov/study/NCT04603001

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.